A landmark study shows the main compound in magic mushrooms could rival a leading depression drug
For the first time, researchers pitted psilocybin, the active compound in magic mushrooms, against a leading antidepressant.
Full Article
A landmark study shows the main compound in magic mushrooms could rival a leading depression drug
Business Insider
0 shares
1 views
You might like
Related news coverage
Psychedelic compound in magic mushrooms 'promising' for treating depression
The active ingredient in magic mushrooms that gives them their psychedelic effect might be as good as, in not better than a leading..
Sky News
Psyched Wellness is pioneering research into the health benefits of Amanita Muscaria mushrooms
Research leader for the health benefits of Amanita Muscaria mushrooms Engaged in pre-clinical trials on the company’s proprietary..
Proactive Investors